LBP AM’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.5M Buy
265,498
+126,932
+92% +$16.7M 0.34% 61
2026
Q1
$19.3M Sell
138,566
-84,738
-38% -$11.9M 0.26% 75
2025
Q4
$27.4M Buy
223,304
+75,182
+51% +$9.14M 0.32% 62
2025
Q3
$16.4M Buy
148,122
+2,528
+2% +$287K 0.2% 100
2025
Q2
$16.1M Sell
145,594
-59,711
-29% -$6.35M 0.23% 92
2025
Q1
$23M Sell
205,305
-7,530
-4% -$777K 0.36% 60
2024
Q4
$19.7M Buy
212,835
+61,948
+41% +$5.58M 0.27% 78
2024
Q3
$12.7M Buy
150,887
+122,615
+434% +$9.36M 0.19% 116
2024
Q2
$1.94M Buy
28,272
+19,283
+215% +$1.29M 0.08% 165
2024
Q1
$658K Sell
8,989
-74,335
-89% -$5.72M 0.03% 292
2023
Q4
$6.75M Sell
83,324
-22,469
-21% -$1.75M 0.15% 149
2023
Q3
$7.93M Buy
105,793
+12,451
+13% +$958K 0.18% 139
2023
Q2
$7.19M Buy
93,342
+56,466
+153% +$4.5M 0.17% 125
2023
Q1
$3.06M Sell
36,876
-3,405
-8% -$282K 0.08% 222
2022
Q4
$3.46M Buy
+40,281
New +$3.19M 0.1% 207

Other funds holding GILD

LBP AM's GILD Position: Q2 2026 in Review

LBP AM increased its Gilead Sciences (GILD) stake by 92% in Q2 2026, buying an estimated $16.7M and bringing the position to 265,498 shares worth $33.5M. The position accounts for 0.34% of the portfolio, ranked #61.

LBP AM first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • LBP AM held 265,498 shares of Gilead Sciences worth $33.5M as of Q2 2026.
  • LBP AM bought 126,932 Gilead Sciences shares in Q2 2026, an estimated $16.7M.
  • Gilead Sciences made up 0.34% of LBP AM's portfolio in Q2 2026, its #61 holding.
  • LBP AM first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on LBP AM's 13F filing for Q2 2026, filed 24 Jul 2026.